Compare The Coca-Cola Co K (KO) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
The Coca-Cola Co K vs Zoetis Inc — how do they compare? The Coca-Cola Co K trades at $81.96 (market cap $353.32B), while Zoetis Inc trades at $75.71 (market cap $31.95B). The key difference: The Coca-Cola Co K is far larger — about 11.1× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| KO | ZTS | |
|---|---|---|
Market Cap | $353.32B | $31.95B |
Volume | 14,630,257 | — |
Sector | Consumer Staples | Health |
52-Week High | $84.92 | $156.76 |
52-Week Low | $65.67 | $71.91 |
Enterprise Value | $383.39B | $39.24B |
Dividend Yield | 2.58% | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Coca-Cola (KO) trades at $81.87, up 0.38% today, with a neutral technical signal and strong fundamentals including a 27.8% net income margin and consistent earnings beats. The stock shows robust profitability with ROE at 45.8% and a dividend yield supported by 64 consecutive years of increases. Recent news highlights institutional buying and stable demand trends ahead of Q2 2026 earnings.
Outlook remains positive with a consensus price target of $90.67, implying ~11% upside. Risks include regional demand divergence and high debt levels. Analyst sentiment is bullish (60% Buy ratings), but investors should monitor execution against earnings expectations and macroeconomic pressures on consumer spending.
Zoetis (ZTS) trades at $76.05, down 0.67% on the day, with a neutral technical signal and bearish moving averages. The company maintains strong fundamentals with a 28.03% net income margin and 67.75% ROE, though Q1 2026 earnings missed expectations. Recent news highlights multiple securities class action lawsuits filed against the company, creating near-term uncertainty despite the launch of new product Lenivia in Canada and EU markets.
The stock presents a mixed outlook with attractive valuation metrics (P/E 12.55) and analyst consensus price target of $101.43 suggesting 33% upside potential. However, legal challenges and the recent earnings miss pose significant near-term risks. Institutional sentiment remains divided with 47% buy ratings versus 53% hold ratings, indicating cautious optimism amid legal headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
